Your browser doesn't support javascript.
loading
Intralesional brentuximab vedotin for the treatment of primary cutaneous T-cell lymphomas: a case series.
Arroyo-Andrés, Jorge; Agud-Dios, Manuel; Rubio-Muniz, Carmen A; Postigo, Concepción; Cortijo-Cascajares, Susana; Ortiz-Romero, Pablo L.
Affiliation
  • Arroyo-Andrés J; Department of Dermatology, 12 de Octubre University Hospital, Madrid, Spain.
  • Agud-Dios M; Department of Dermatology, 12 de Octubre University Hospital, Madrid, Spain.
  • Rubio-Muniz CA; Department of Dermatology, 12 de Octubre University Hospital, Madrid, Spain.
  • Postigo C; Department of Dermatology, 12 de Octubre University Hospital, Madrid, Spain.
  • Cortijo-Cascajares S; Pharmacy Department, 12 de Octubre University Hospital, Madrid, Spain.
  • Ortiz-Romero PL; Department of Dermatology, 12 de Octubre University Hospital, Madrid, Spain.
Int J Dermatol ; 63(2): e57-e59, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38093412

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Lymphoma, T-Cell, Cutaneous / Immunoconjugates Limits: Humans Language: En Journal: Int J Dermatol Year: 2024 Document type: Article Affiliation country: Spain Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Lymphoma, T-Cell, Cutaneous / Immunoconjugates Limits: Humans Language: En Journal: Int J Dermatol Year: 2024 Document type: Article Affiliation country: Spain Country of publication: United kingdom